RGPD6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.973000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.319000E-01
Normal-vs-Stage2
2.623800E-01
Normal-vs-Stage3
1.531580E-02
Normal-vs-Stage4
5.981800E-01
Stage1-vs-Stage2
3.374200E-01
Stage1-vs-Stage3
1.153440E-01
Stage1-vs-Stage4
8.892200E-01
Stage2-vs-Stage3
1.493960E-01
Stage2-vs-Stage4
5.561000E-01
Stage3-vs-Stage4
1.423810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.394600E-01
Normal-vs-AfricanAmerican
2.860600E-01
Normal-vs-Asian
1.194010E-01
Caucasian-vs-AfricanAmerican
7.775200E-01
Caucasian-vs-Asian
2.090600E-01
AfricanAmerican-vs-Asian
5.270400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.850000E-01
Normal-vs-Female
4.319600E-01
Male-vs-Female
7.401800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.629200E-01
Normal-vs-Age(41-60Yrs)
6.994600E-01
Normal-vs-Age(61-80Yrs)
3.353800E-01
Normal-vs-Age(81-100Yrs)
5.238600E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.800200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.236600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.845000E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.688000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.785000E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.716500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.600970E-01
Normal-vs-Daily Drinker
2.053200E-01
Normal-vs-Weekly Drinker
2.203600E-01
Normal-vs-Occasional Drinker
7.785600E-01
Normal-vs-Social Drinker
4.455000E-01
Non Drinker-vs-Daily Drinker
9.499800E-01
Non Drinker-vs-Weekly Drinker
6.256800E-01
Non Drinker-vs-Occasional Drinker
1.777640E-01
Non Drinker-vs-Social Drinker
2.193800E-01
Daily Drinker-vs-Weekly Drinker
6.297000E-01
Daily Drinker-vs-Occasional Drinker
1.831040E-01
Daily Drinker-vs-Social Drinker
2.569200E-01
Weekly Drinker-vs-Occasional Drinker
3.096200E-01
Weekly Drinker-vs-Social Drinker
5.030200E-01
Occasional Drinker-vs-Social Drinker
5.635000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.582400E-01
Normal-vs-Grade 2
1.275210E-01
Normal-vs-Grade 3
9.847900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.370200E-01
Grade 1-vs-Grade 3
4.379800E-01
Grade 1-vs-Grade 4
2.582400E-01
Grade 2-vs-Grade 3
4.597600E-01
Grade 2-vs-Grade 4
1.275210E-01
Grade 3-vs-Grade 4
9.847900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.904790E-01
Normal-vs-NonDiabetic
4.628600E-01
Diabetic-vs-NonDiabetic
2.658600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.146400E-01
Normal-vs-NoPancreatitis
3.739800E-01
Pancreatitis-vs-NoPancreatitis
9.231000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.785700E-02
Normal-vs-N1
3.157200E-01
N0-vs-N1
9.188800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.479600E-01
Normal-vs-TP53-NonMutant
7.550000E-01
TP53-Mutant-vs-TP53-NonMutant
4.188200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
